Dynavax Technologies Files Proxy Materials
| Field | Detail |
|---|---|
| Company | Dynavax Technologies Corp |
| Form Type | DEFA14A |
| Filed Date | May 19, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: proxy-statement, shareholder-communication
TL;DR
DYNA proxy filing out - shareholders getting updates.
AI Summary
Dynavax Technologies Corporation filed a Definitive Additional Materials (DEFA14A) proxy statement on May 19, 2025. This filing is related to materials distributed to its stockholders. The company is incorporated in Delaware and its fiscal year ends on December 31.
Why It Matters
This filing indicates that Dynavax is communicating important information to its shareholders, likely concerning upcoming votes or corporate actions.
Risk Assessment
Risk Level: low — This is a routine proxy filing and does not contain information that inherently increases risk for investors.
Key Players & Entities
- Dynavax Technologies Corporation (company) — Registrant
- 20250519 (date) — Filing Date
- DEFA14A (document_type) — Filing Type
FAQ
What type of SEC filing is this?
This is a DEFA14A filing, specifically 'Definitive Additional Materials'.
Who is the filing company?
The filing company is Dynavax Technologies Corporation.
When was this filing submitted?
The filing was submitted on May 19, 2025.
What is the company's primary business classification?
The company's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Where is Dynavax Technologies Corporation located?
The company's business and mailing address is 2100 Powell Street, Suite 720, Emeryville, CA 94608.
Filing Details
This Form DEFA14A (Form DEFA14A) was filed with the SEC on May 19, 2025 regarding DYNAVAX TECHNOLOGIES CORP.